Research advances in transarterial chemoembolization combined with sorafenib in treatment of advanced hepatocellular carcinoma
In: Linchuang Gandanbing Zazhi, Jg. 34 (2018), Heft 4, S. 867-871
Online
academicJournal
Zugriff:
At present, transarterial chemoembolization (TACE) combined with sorafenib is commonly used for patients with advanced hepatocellular carcinoma (HCC) who have lost the opportunity for surgery, and yet no consensus has been reached on the specific therapeutic paradigm. This article reviews the treatment modes of TACE combined with sorafenib and their effect and safety in the treatment of HCC. It is pointed out that these treatment modes have their own advantages and disadvantages and await further clinical studies, in order to provide a reference for the treatment of patients with advanced HCC.
Titel: |
Research advances in transarterial chemoembolization combined with sorafenib in treatment of advanced hepatocellular carcinoma
|
---|---|
Autor/in / Beteiligte Person: | Lei, WU ; Su, WANG |
Link: | |
Zeitschrift: | Linchuang Gandanbing Zazhi, Jg. 34 (2018), Heft 4, S. 867-871 |
Veröffentlichung: | Editorial Department of Journal of Clinical Hepatology, 2018 |
Medientyp: | academicJournal |
ISSN: | 1001-5256 (print) |
DOI: | 10.3969/j.issn.1001-5256.2018.04.037 |
Schlagwort: |
|
Sonstiges: |
|